Tongling Jieya Biologic Technology Co., Ltd.

Equities

301108

CNE1000054S9

Personal Products

End-of-day quote Shenzhen S.E. 18:00:00 2024-06-27 EDT 5-day change 1st Jan Change
24.31 CNY -0.04% Intraday chart for Tongling Jieya Biologic Technology Co., Ltd. -2.99% -29.62%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tongling Jieya Biologic Technology Co., Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 13 June 2024 CI
Tongling Jieya Biologic Technology Co., Ltd. Approves Cash Dividend for the Year 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. commences an Equity Buyback Plan for CNY 40 million worth of its shares, under the authorization approved on March 13, 2024. CI
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2023. CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. agreed to acquire 20% stake in Sateri Nonwoven Materials Co., Ltd. from Sateri Fiber Co., Ltd. for CNY 16.5 million. CI
Tongling Jieya Biologic Technology Co., Ltd. Approves Cash Dividend on A shares for 2022, Payable on 26 May 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for 2022 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2022. CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tongling Jieya Biologic to Free Up More than 1 Milion Shares For Trading MT
Tongling Jieya Biologic Technology Co., Ltd. Approves Final Cash Dividend for the Year 2021 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tongling Jieya Biologic Technology Co., Ltd. has completed an IPO in the amount of CNY 1.162722 billion. CI
Tongling Jieya Biologic Technology Co., Ltd. has filed an IPO. CI
Chart Tongling Jieya Biologic Technology Co., Ltd.
More charts
Tongling Jieya Biologic Technology Co Ltd is a China-based company mainly engaged in the production of wipes. The Company's main businesses are the research and development, production and sales of sanitary products. The Company's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The Company is also engaged in the production of facial masks.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
24.31 CNY
Average target price
35 CNY
Spread / Average Target
+43.97%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301108 Stock
  4. News Tongling Jieya Biologic Technology Co., Ltd.
  5. Tongling Jieya Biologic to Free Up More than 1 Milion Shares For Trading